Post by account_disabled on Jan 7, 2024 20:11:19 GMT -8
AstraZeneca Thailand in collaboration with Health Region Office 1, Ministry of Public Health (Chiang Mai, Chiang Rai, Lamphun, Lampang, Phrae, Nan, Phayao and Mae Hong Son provinces) organized an academic seminar on "Medical services in 'New normal' to deal with COVID-19 for patients with chronic obstructive pulmonary disease (COPD) and asthma (Asthma)" to transfer new knowledge From doctors.
Who are experts in treatment and Phone Number Data care for patients with chronic obstructive pulmonary disease and asthma. Including the impact of PM 2.5 on respiratory diseases. to medical personnel in Public Health District 1. In addition, AstraZeneca (Thailand) Company Limited, led by Dr. Korn Tanthip, Medical Director, and Mr. Michael Mingwei Kwan, Business Unit Director Respiratory & Immunology and Vaccines & Immune.
Therapies has awarded 20 scholarships for training spirometry personnel to be used to develop the potential of caring for patients with chronic obstructive pulmonary disease and asthma, led by Dr. Kanok. Phiphatwet, respiratory internist and the Chairman of the Service System Development Committee for the Chronic Obstructive Pulmonary Disease Branch.
Who are experts in treatment and Phone Number Data care for patients with chronic obstructive pulmonary disease and asthma. Including the impact of PM 2.5 on respiratory diseases. to medical personnel in Public Health District 1. In addition, AstraZeneca (Thailand) Company Limited, led by Dr. Korn Tanthip, Medical Director, and Mr. Michael Mingwei Kwan, Business Unit Director Respiratory & Immunology and Vaccines & Immune.
Therapies has awarded 20 scholarships for training spirometry personnel to be used to develop the potential of caring for patients with chronic obstructive pulmonary disease and asthma, led by Dr. Kanok. Phiphatwet, respiratory internist and the Chairman of the Service System Development Committee for the Chronic Obstructive Pulmonary Disease Branch.